Drug Discovery Conference 2019

Thought Leaders & Visionaries

Armin Bauer

Director External Cooperations

Sanofi-Aventis

After the huge success of our back to back conferences in Europe and U.S., we at World BI, are beyond excited for 2019 events taking place in Frankfurt, Boston, San Francisco & Barcelona.

DDIP has always proven to be a unique platform to meet senior level executives, key decision makers and experts all-around the Academic Institutions, Pharmaceutical, Biotech and lead researchers making the congress a perfect platform to share experience, foster collaborations to put forward many thought provoking strategies.

If you hope to discover new ideas, search for new skills and a platform to show your capabilities and discoveries to the world, there couldn’t be a better place for you to be on April 11-12 2019!

Register

Don't Take It From Us; Take It From Our Clients

Hear what our attendees had to say for us

We have thoroughly enjoyed the DDIP and the talks by various speakers. It was a truly wonderful experience to see various standpoints, out of the box thinking by several scientists, approaches to accelerate drug discovery and reasonable networking opportunities.

Sai Life Sciences

The event was very well organized in a comfortable environment and atmosphere. The quality of the presentations was extremely good and respectful of the timing.

L’oreal

Thank you for having me at the 6th DDIP event. It was very informative and gave me a new perspective about the drug developments world on big pharma’s. It was also very important for research and busyness connecting.

University of Beira Interior

I experienced a very positive and fresh meeting based on factors:
- Chairpersons were very competent and kept the pace including Q&A
- Topics were up to date – best about orphan drugs – positive heated debate – very interesting (!)
- Diversity of topics key – a good mix with borderline areas like cosmetics – very good

DanPet AB

It was my pleasure to give the talk at the 6th DDIP in Frankfurt. I really enjoyed the conference and I think it was a great agenda with a lot of interesting and diverse talks.

AstraZeneca

I enjoyed the meeting very much and it was very informative. I particular enjoyed the mix of the topics, which was unusual but generated a lot of engagement.

AstraZeneca

It was really a pleasure for me to attend this event. I like it very much due to the broad range of topics covered and also of the facility to interact with other participants.

F. Hoffmann-La Roche